1
|
Hanna DH, Aziz MM, Shafee EE. Effective-by-method for the preparation of folic acid-coated TiO 2 nanoparticles with high targeting potential for apoptosis induction against bladder cancer cells (T24). Biotechnol Appl Biochem 2023; 70:1597-1615. [PMID: 36905187 DOI: 10.1002/bab.2456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2022] [Accepted: 02/25/2023] [Indexed: 03/12/2023]
Abstract
The research's goal is to create the surfaces of titanium dioxide nanoparticles (TiO2 NPs) in a layer of folic acid (FA) that can effectively target human bladder cancer cells (T24). An efficient method for creating FA-coated TiO2 NPs was used, and many tools have been used to analyze its physicochemical properties. The cytotoxic effects of FA-coated NPs on T24 cells and the mechanisms of apoptosis generation were examined employing a variety of methodologies. The prepared FA-coated TiO2 NPs suspensions with a hydrodynamic diameter around 37 nm and a negative surface charge of -30 mV reduced T24 cell proliferation with stronger IC50 value (21.8 ± 1.9 μg/ml) than TiO2 NPs (47.8 ± 2.5 μg/ml). This toxicity resulted in apoptosis induction (16.63%) that was caused through enhanced reactive oxygen species formation and stopping the cell cycle over G2/M phase. Moreover, FA-TiO2 NPs raised the expression levels of P53, P21, BCL2L4, and cleaved Caspase-3, while decreasing Bcl-2, Cyclin B, and CDK1 in treated cells. Overall, these findings revealed efficient targeting of the FA-TiO2 NPs resulted in increasing cellular internalization caused increased apoptosis in T24 cells. As a result, FA-TiO2 NPs might be a viable treatment for human bladder cancer.
Collapse
Affiliation(s)
- Demiana H Hanna
- Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt
| | - Marina M Aziz
- Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt
| | - E El Shafee
- Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt
| |
Collapse
|
2
|
Alshammari MK, Alghazwni MK, Alharbi AS, Alqurashi GG, Kamal M, Alnufaie SR, Alshammari SS, Alshehri BA, Tayeb RH, Bougeis RJM, Aljehani AA, Alotaibi NM, Abida A, Imran M. Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy. Cancers (Basel) 2022; 15:cancers15010065. [PMID: 36612067 PMCID: PMC9817931 DOI: 10.3390/cancers15010065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 12/16/2022] [Accepted: 12/20/2022] [Indexed: 12/25/2022] Open
Abstract
Chemotherapy has been the predominant treatment modality for cancer patients, but its overall performance is still modest. Difficulty in penetration of tumor tissues, a toxic profile in high doses, multidrug resistance in an array of tumor types, and the differential architecture of tumor cells as they grow are some of the bottlenecks associated with the clinical usage of chemotherapeutics. Recent advances in tumor biology understanding and the emergence of novel targeted drug delivery tools leveraging various nanosystems offer hope for developing effective cancer treatments. Topotecan is a topoisomerase I inhibitor that stabilizes the transient TOPO I-DNA cleavable complex, leading to single-stranded breaks in DNA. Due to its novel mechanism of action, TOPO is reported to be active against various carcinomas, namely small cell lung cancer, cervical cancer, breast cancer, and ovarian cancer. Issues of cross-resistance with numerous drugs, rapid conversion to its inactive form in biological systems, appended adverse effects, and higher water solubility limit its therapeutic efficacy in clinical settings. Topotecan nanoformulations offer several benefits for enhancing the therapeutic action of this significant class of chemotherapeutics. The likelihood that the target cancer cells will be exposed to the chemotherapeutic drug while in the drug-sensitive s-phase is increased due to the slow and sustained release of the chemotherapeutic, which could provide for a sustained duration of exposure of the target cancer cells to the bioavailable drug and result in the desired therapeutic outcome. This article explores nanoenabled active and passive targeting strategies and combinatorial therapy employing topotecan to ameliorate various cancers, along with a glimpse of the clinical studies utilizing the said molecule.
Collapse
Affiliation(s)
- Mohammed Kanan Alshammari
- Department of Clinical Pharmacy, King Fahad Medical City, Riyadh 12211, Saudi Arabia
- Correspondence: (M.K.A.); (M.I.)
| | | | - Abrar Saleh Alharbi
- Department of Pharmaceutical Sciences, Maternity and Children’s Hospital, Mecca 24246, Saudi Arabia
| | | | - Mehnaz Kamal
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
| | - Salman Rahim Alnufaie
- Department of Infection Control, Riyadh Third Health Cluster, Riyadh 13223, Saudi Arabia
| | - Salem Sayer Alshammari
- Department of Pharmaceutical Care, Al-Dawaa Medical Services, Jubail 35412, Saudi Arabia
| | - Bandar Ali Alshehri
- Laboratory Department, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia
| | - Rami Hatem Tayeb
- Laboratory Department, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia
| | | | - Alaa Adel Aljehani
- Laboratory Department, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia
| | - Nawaf M. Alotaibi
- Department of Clinical Pharmacy, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
| | - Abida Abida
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
| | - Mohd. Imran
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
- Correspondence: (M.K.A.); (M.I.)
| |
Collapse
|
3
|
Escriche‐Navarro B, Escudero A, Lucena‐Sánchez E, Sancenón F, García‐Fernández A, Martínez‐Máñez R. Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2022; 9:e2200756. [PMID: 35866466 PMCID: PMC9475525 DOI: 10.1002/advs.202200756] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/08/2022] [Revised: 05/16/2022] [Indexed: 05/16/2023]
Abstract
Cancer immunotherapy has emerged in the past decade as a promising strategy for treating many forms of cancer by stimulating the patient's immune system. Although immunotherapy has achieved some promising results in clinics, more efforts are required to improve the limitations of current treatments related to lack of effective and targeted cancer antigens delivery to immune cells, dose-limiting toxicity, and immune-mediated adverse effects, among others. In recent years, the use of nanomaterials has proven promising to enhance cancer immunotherapy efficacy and reduce side effects. Among nanomaterials, attention has been recently paid to mesoporous silica nanoparticles (MSNs) as a potential multiplatform for enhancing cancer immunotherapy by considering their unique properties, such as high porosity, and good biocompatibility, facile surface modification, and self-adjuvanticity. This review explores the role of MSN and other nano/micro-materials as an emerging tool to enhance cancer immunotherapy, and it comprehensively summarizes the different immunotherapeutic strategies addressed to date by using MSN.
Collapse
Affiliation(s)
- Blanca Escriche‐Navarro
- Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) Polytechnic University of Valencia‐University of ValenciaCamino de Vera s/nValencia46022Spain
- Universitat Politècnica de ValènciaJoint Unit UPV‐CIPF of Developmental Biology and Disease Models and Nanomedicine, Polytechnic University of Valencia (UPV)‐Príncipe Felipe Research Center Foundation (CIPF)C/ Eduardo Primo Yúfera 3.Valencia46012Spain
- Joint Unit of Nanomedicine and Sensors, Polytechnic University of Valencia, IIS La FeAv. Fernando Abril Martorell, 106Valencia46026Spain
| | - Andrea Escudero
- Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) Polytechnic University of Valencia‐University of ValenciaCamino de Vera s/nValencia46022Spain
- Universitat Politècnica de ValènciaJoint Unit UPV‐CIPF of Developmental Biology and Disease Models and Nanomedicine, Polytechnic University of Valencia (UPV)‐Príncipe Felipe Research Center Foundation (CIPF)C/ Eduardo Primo Yúfera 3.Valencia46012Spain
| | - Elena Lucena‐Sánchez
- Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) Polytechnic University of Valencia‐University of ValenciaCamino de Vera s/nValencia46022Spain
- Universitat Politècnica de ValènciaJoint Unit UPV‐CIPF of Developmental Biology and Disease Models and Nanomedicine, Polytechnic University of Valencia (UPV)‐Príncipe Felipe Research Center Foundation (CIPF)C/ Eduardo Primo Yúfera 3.Valencia46012Spain
| | - Félix Sancenón
- Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) Polytechnic University of Valencia‐University of ValenciaCamino de Vera s/nValencia46022Spain
- Universitat Politècnica de ValènciaJoint Unit UPV‐CIPF of Developmental Biology and Disease Models and Nanomedicine, Polytechnic University of Valencia (UPV)‐Príncipe Felipe Research Center Foundation (CIPF)C/ Eduardo Primo Yúfera 3.Valencia46012Spain
- Joint Unit of Nanomedicine and Sensors, Polytechnic University of Valencia, IIS La FeAv. Fernando Abril Martorell, 106Valencia46026Spain
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER‐BBN)Av. Monforte de Lemos, 3–5. Pabellón 11., Planta 0Madrid28029Spain
| | - Alba García‐Fernández
- Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) Polytechnic University of Valencia‐University of ValenciaCamino de Vera s/nValencia46022Spain
- Universitat Politècnica de ValènciaJoint Unit UPV‐CIPF of Developmental Biology and Disease Models and Nanomedicine, Polytechnic University of Valencia (UPV)‐Príncipe Felipe Research Center Foundation (CIPF)C/ Eduardo Primo Yúfera 3.Valencia46012Spain
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER‐BBN)Av. Monforte de Lemos, 3–5. Pabellón 11., Planta 0Madrid28029Spain
| | - Ramón Martínez‐Máñez
- Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) Polytechnic University of Valencia‐University of ValenciaCamino de Vera s/nValencia46022Spain
- Universitat Politècnica de ValènciaJoint Unit UPV‐CIPF of Developmental Biology and Disease Models and Nanomedicine, Polytechnic University of Valencia (UPV)‐Príncipe Felipe Research Center Foundation (CIPF)C/ Eduardo Primo Yúfera 3.Valencia46012Spain
- Joint Unit of Nanomedicine and Sensors, Polytechnic University of Valencia, IIS La FeAv. Fernando Abril Martorell, 106Valencia46026Spain
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER‐BBN)Av. Monforte de Lemos, 3–5. Pabellón 11., Planta 0Madrid28029Spain
| |
Collapse
|
4
|
Hao Y, Li X. Deacetylated-poly-N-acetylglucosamine-folic Acid as a Nanocarrier for Delivering miR-196a Inhibitor to Anticancer Activity. Balkan Med J 2022; 39:55-65. [PMID: 35330543 PMCID: PMC8941238 DOI: 10.4274/balkanmedj.galenos.2021.2021-8-62] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
5
|
Hanna DH, R. Saad G. Induction of mitochondria mediated apoptosis in human ovarian cancer cells by folic acid coated tin oxide nanoparticles. PLoS One 2021; 16:e0258115. [PMID: 34597348 PMCID: PMC8486119 DOI: 10.1371/journal.pone.0258115] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Accepted: 09/17/2021] [Indexed: 12/15/2022] Open
Abstract
PURPOSE This study aims to prepare folic acid coated tin oxide nanoparticles (FA-SnO2 NPs) for specifically targeting human ovarian cancer cells with minimum side effects against normal cells. METHODS The prepared FA-SnO2 NPs were characterized by FT-IR, UV-vis spectroscopy, XRD, SEM and TEM. The inhibition effects of FA-SnO2 NPs against SKOV3 cancer cell were tested by MTT and LDH assay. Apoptosis induction in FA-SnO2 NPs treated SKOV3 cells were investigated using Annexin V/PI, AO/EB and Comet assays and the possible mechanisms of the cytotoxic action were studied by Flow cytometry, qRT-PCR, Immunohistochemistry, and Western blotting analyses. The effects of FA-SnO2 NPs on reactive oxygen species generation in SKOV3 cells were also examined. Additionally, the safety of utilization FA-SnO2 NPs were studied in vivo using Wister rats. RESULTS The obtained FA-SnO2 NPs displayed amorphous spherical morphology with an average diameter of 157 nm and a zeta potential value of -24 mV. Comparing to uncoated SnO2 NPs, FA-SnO2 NPs had a superior inhibition effect towards SKOV3 cell growth that was suggested to be mediated through higher reactive oxygen species generation. It was showed that FA-SnO2 NPs increased significantly the % of apoptotic cells in the sub- G1 and G2/M phases with a higher intensity comet nucleus in SKOV3 treated cells. Furthermore, FA-SnO2 NPs was significantly increased the expression levels of P53, Bax, and cleaved Caspase-3 and accompanied with a significant decrease of Bcl-2 in the treated SKOV3 cells. CONCLUSION Overall, the results suggested that an increase in cellular FA-SnO2 NPs internalization resulted in a significant induced cytotoxicity in SKOV3 cancer cells in dose-dependent mode through ROS-mediated cell apoptosis that may have occurred through mitochondrial pathway. Additionally, the results confirmed the safety of utilization FA-SnO2 NPs against living systems. So, FA-SnO2 NPs with a specific targeting moiety may be a promising therapeutic candidate for human ovarian cancer.
Collapse
Affiliation(s)
- Demiana H. Hanna
- Faculty of Science, Department of Chemistry, Cairo University, Giza, Egypt
| | - Gamal R. Saad
- Faculty of Science, Department of Chemistry, Cairo University, Giza, Egypt
| |
Collapse
|
6
|
Liang X, Fan J, Zhao Y, Jin R. Synthesis of NaYF4:Yb,Er upconversion nanoparticle-based optomagnetic multifunctional composite for drug delivery system. J RARE EARTH 2021. [DOI: 10.1016/j.jre.2020.08.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
7
|
Liang X, Fan J, Zhao Y, Jin R. Core–Shell Structured NaYF4:Yb,Er Nanoparticles with Excellent Upconversion Luminescent for Targeted Drug Delivery. J CLUST SCI 2020. [DOI: 10.1007/s10876-020-01929-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
8
|
Chen W, Xie Y, Wang M, Li C. Recent Advances on Rare Earth Upconversion Nanomaterials for Combined Tumor Near-Infrared Photoimmunotherapy. Front Chem 2020; 8:596658. [PMID: 33240857 PMCID: PMC7677576 DOI: 10.3389/fchem.2020.596658] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Accepted: 10/07/2020] [Indexed: 01/23/2023] Open
Abstract
Cancer has been threatening the safety of human life. In order to treat cancer, many methods have been developed to treat tumor, such as traditional therapies like surgery, chemotherapy, radiotherapy, as well as new strategies like photodynamic therapy, photothermal therapy, sonodynamic therapy, and other emerging therapies. Although there are so many ways to treat tumors, these methods all face the dilemma that they are incapable to cope with metastasis and recurrence of tumors. The emergence of immunotherapy has given the hope to conquer the challenge. Immunotherapy is to use the body's own immune system to stimulate and maintain a systemic immune response to form immunological memory, resist the metastasis and recurrence of tumors. At the same time, immunotherapy can combine with other treatments to exhibit excellent antitumor effects. Upconversion nanoparticles (UCNPs) can convert near-infrared (NIR) light into ultraviolet and visible light, thus have good performance in bioimaging and NIR triggered phototherapy. In this review paper, we summarize the design, fabrication, and application of UCNPs-based NIR photoimmunotherapy for combined cancer treatment, as well as put forward the prospect of future development.
Collapse
Affiliation(s)
- Weilin Chen
- Institute of Frontier and Interdisciplinarity Science, Institute of Molecular Sciences and Engineering, Shandong University, Qingdao, China
| | - Yulin Xie
- Institute of Frontier and Interdisciplinarity Science, Institute of Molecular Sciences and Engineering, Shandong University, Qingdao, China
| | - Man Wang
- Institute of Frontier and Interdisciplinarity Science, Institute of Molecular Sciences and Engineering, Shandong University, Qingdao, China
| | - Chunxia Li
- Institute of Frontier and Interdisciplinarity Science, Institute of Molecular Sciences and Engineering, Shandong University, Qingdao, China
| |
Collapse
|
9
|
Chávez-García D, Juarez-Moreno K, Calderón-Osuna I, Navarro P, Hirata GA. Nanotoxicological study of downconversion Y 2 O 3 :Eu 3+ luminescent nanoparticles functionalized with folic acid for cancer cells bioimaging. J Biomed Mater Res B Appl Biomater 2020; 108:2396-2406. [PMID: 32017405 DOI: 10.1002/jbm.b.34572] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2019] [Revised: 12/11/2019] [Accepted: 01/12/2020] [Indexed: 12/12/2022]
Abstract
Luminescent lanthanide downconversion nanoparticles (DCNPs) provide a combination of high luminescence intensity, sharp emission peaks with narrow bandwidth and a large Stokes' shift, leading to high-performance biomedical applications mainly for imaging. The purpose of this study is to present a nanotoxicological study of DCNPs Y2 O3 codoped with Eu3+ and functionalized with folic acid (FA). These assessments include cytotoxicity, genotoxicity, hemocompatibility, and in vitro inflammatory studies. We demonstrated by flow cytometry and confocal microscope the internalization of FA-DCNPs in breast cancer and melanoma cells. They were synthesized by sol-gel method and coated with a thin silica shell to make them biocompatible; also they were functionalized with amino groups and FA ligands that bind to the folate receptors (FR) located on the surface of the cancer cells studied. This functionalization enables the DCNPs to be internalized into the cancer cells via endocytosis by the conjugation FA-FR. The DCNPs were characterized with transmission electron microscope, Fourier transform infrared spectroscopy and photoluminescence. The nanotoxicological assessments demonstrated that both nanoparticles (bare and functionalized) are no cytotoxic and no genotoxic at the tested concentrations (0.01-20 μg/mL) in three cell lines (breast, skin cancer, and osteoblasts). Also they are hemocompatible and do not exert nitric oxide production in vitro by macrophages. The FA-DCNPs were clearly localized into the cell cytoplasm with bright red luminescence. Thus, herein we present a complete nanotoxicological study of FA-DCNPs Y2 O3 codoped with Eu3+ and we conclude that these nanoparticles are biocompatible and can be further used for cancer cells bioimaging.
Collapse
Affiliation(s)
- Dalia Chávez-García
- School of Engineering, Centro de Enseñanza Técnica y Superior (CETYS), Ensenada, Mexico
| | - Karla Juarez-Moreno
- Bionanotechnology Department, Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, CNyN-UNAM, Ensenada, Mexico.,Cátedras, CONACYT-CNyN-UNAM, Ensenada, Mexico
| | - Itamar Calderón-Osuna
- School of Engineering, Centro de Enseñanza Técnica y Superior (CETYS), Ensenada, Mexico
| | - Patricia Navarro
- School of Engineering, Centro de Enseñanza Técnica y Superior (CETYS), Ensenada, Mexico
| | - Gustavo A Hirata
- Physicochemistry Department, Centro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México, CNyN-UNAM Ensenada, Mexico
| |
Collapse
|
10
|
Farran B, Montenegro RC, Kasa P, Pavitra E, Huh YS, Han YK, Kamal MA, Nagaraju GP, Rama Raju GS. Folate-conjugated nanovehicles: Strategies for cancer therapy. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2019; 107:110341. [PMID: 31761235 DOI: 10.1016/j.msec.2019.110341] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Revised: 09/02/2019] [Accepted: 10/19/2019] [Indexed: 02/06/2023]
Abstract
Cancer theranostics represents a strategy that aims at combining diagnosis with therapy through the simultaneous imaging and targeted delivery of therapeutics to cancer cells. Recently, the folate receptor alpha has emerged as an attractive theranostic target due to its overexpression in multiple solid tumors and its great functional versatility. In fact, it can be incorporated into folate-conjugated nano-systems for imaging and drug delivery. Hence, it can be used along the line of personalized clinical strategies as both an imaging tool and a delivery method ensuring the selective transport of treatments to tumor cells, thus highlighting its theranostic qualities. In this review, we will explore these theranostic characteristics in detail and assess their clinical potential. We will also discuss the technological advances that have allowed the design of sophisticated folate-based nanocarriers harboring various chemical properties and suited for the transport of various therapeutic agents.
Collapse
Affiliation(s)
- Batoul Farran
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA
| | - Raquel Carvalho Montenegro
- Biological Science Institute, Federal University of Para, Augusto Correa Avenue, 01 Guamá, Belém, Pará, Brazil
| | - Prameswari Kasa
- Dr. LV Prasad Diagnostics and Research Laboratory, Khairtabad, Hyderabad, AP, 500004, India
| | - Eluri Pavitra
- Department of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, 100, Inha-ro, Incheon, 22212, Republic of Korea
| | - Yun Suk Huh
- Department of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, 100, Inha-ro, Incheon, 22212, Republic of Korea
| | - Young-Kyu Han
- Department of Energy and Materials Engineering, Dongguk University-Seoul, Seoul, 04620, Republic of Korea
| | - Mohammad Amjad Kamal
- King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah, 21589, Saudi Arabia; Enzymoics, 7 Peterlee Place, Hebersham, NSW, 2770, Australia; Novel Global Community Educational Foundation, Australia
| | - Ganji Purnachandra Nagaraju
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA
| | - Ganji Seeta Rama Raju
- Department of Energy and Materials Engineering, Dongguk University-Seoul, Seoul, 04620, Republic of Korea.
| |
Collapse
|
11
|
Wimalachandra DC, Li Y, Liu J, Shikha S, Zhang J, Lim YC, Zhang Y. Microfluidic-Based Immunomodulation of Immune Cells Using Upconversion Nanoparticles in Simulated Blood Vessel-Tumor System. ACS APPLIED MATERIALS & INTERFACES 2019; 11:37513-37523. [PMID: 31547654 DOI: 10.1021/acsami.9b15178] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The goal of cancer immunotherapy is the selective killing of malignant cells by the cooperated efforts of immune cells at the primary and secondary sites. Here, we developed folic acid and secondary lymphoid tissue chemokine-loaded mesoporous silica-modified upconversion nanoparticle construct as a targeting, delivery, and imaging system to attract immune cells to folate receptor-expressing tumor cells. The effectiveness of the nanoparticles in targeting dendritic cells and T cells to the tumor compartment was tested in a vasculature-tumor interface model constructed from the co-culture of endothelial cells and ovarian cancer cells, in different interconnected channels in a microfluidic device. In comparison to the unconjugated nanoparticles, the folic acid-conjugated nanoparticles efficiently diffuse across the engineered blood vessel and specifically target the folate receptor-expressing ovarian cancer cells. The developed microfluidic platform was further used to demonstrate increased dendritic cell and T cell migration toward the ovarian cancer cell channel induced by the presence of the chemokine- and folic acid-loaded nanoparticles. The nanoparticle construct did not exhibit any significant cyto- and hemotoxicity. This proof of concept showed the potential of the nanoparticles to target cancer cells as well as to recruit dendritic cells and T cells to tumor sites to augment the weak host immune response.
Collapse
Affiliation(s)
| | - Yong Li
- School of Environmental and Chemical Engineering , Shanghai University , 99 Shangda Road , 200444 Shanghai , China
| | - Jinliang Liu
- School of Environmental and Chemical Engineering , Shanghai University , 99 Shangda Road , 200444 Shanghai , China
| | - Swati Shikha
- Department of Biomedical Engineering, Faculty of Engineering , National University of Singapore , Singapore 117583
| | - Jing Zhang
- School of Environmental and Chemical Engineering , Shanghai University , 99 Shangda Road , 200444 Shanghai , China
| | - Yaw-Chyn Lim
- Departments of Pathology and Physiology, Yong Loo Lin School of Medicine , National University of Singapore , Singapore 119074
| | - Yong Zhang
- Department of Biomedical Engineering, Faculty of Engineering , National University of Singapore , Singapore 117583
| |
Collapse
|
12
|
All AH, Zeng X, Teh DBL, Yi Z, Prasad A, Ishizuka T, Thakor N, Hiromu Y, Liu X. Expanding the Toolbox of Upconversion Nanoparticles for In Vivo Optogenetics and Neuromodulation. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2019; 31:e1803474. [PMID: 31432555 DOI: 10.1002/adma.201803474] [Citation(s) in RCA: 92] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Revised: 06/12/2019] [Indexed: 06/10/2023]
Abstract
Optogenetics is an optical technique that exploits visible light for selective neuromodulation with spatio-temporal precision. Despite enormous effort, the effective stimulation of targeted neurons, which are located in deeper structures of the nervous system, by visible light, remains a technical challenge. Compared to visible light, near-infrared illumination offers a higher depth of tissue penetration owing to a lower degree of light attenuation. Herein, an overview of advances in developing new modalities for neural circuitry modulation utilizing upconversion-nanoparticle-mediated optogenetics is presented. These developments have led to minimally invasive optical stimulation and inhibition of neurons with substantially improved selectivity, sensitivity, and spatial resolution. The focus is to provide a comprehensive review of the mechanistic basis for evaluating upconversion parameters, which will be useful in designing, executing, and reporting optogenetic experiments.
Collapse
Affiliation(s)
- Angelo Homayoun All
- Department of Biomedical Engineering & Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA
| | - Xiao Zeng
- Department of Chemistry, National University of Singapore, Singapore, 117543, Singapore
| | - Daniel Boon Loong Teh
- Department of Medicine & Singapore Institute for Neurotechnology (SINAPSE), National University of Singapore, Singapore, 117456, Singapore
| | - Zhigao Yi
- Department of Chemistry, National University of Singapore, Singapore, 117543, Singapore
| | - Ankshita Prasad
- Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore
| | - Toru Ishizuka
- Department of Integrative Life Sciences, Tohoku University Graduate School of Life Sciences, Sendai, 980-8577, Japan
| | - Nitish Thakor
- Department of Biomedical Engineering & Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA
- Department of Medicine & Singapore Institute for Neurotechnology (SINAPSE), National University of Singapore, Singapore, 117456, Singapore
- Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore
| | - Yawo Hiromu
- Department of Integrative Life Sciences, Tohoku University Graduate School of Life Sciences, Sendai, 980-8577, Japan
| | - Xiaogang Liu
- Department of Chemistry, National University of Singapore, Singapore, 117543, Singapore
- Center for Functional Materials, National University of Singapore Suzhou Research Institute, Suzhou, Jiangsu, 215123, China
| |
Collapse
|
13
|
Zhong Y, Wang Y, Luo L, Nurhidayah D, Maruf A, Gregersen H, Wu W, Wang GX. Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications. NANOTECHNOLOGY 2019; 30:145601. [PMID: 30524021 DOI: 10.1088/1361-6528/aaf41a] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The development of the tumor-targeting ability of nanocarriers is of paramount importance for gene delivery into tumor lesions as well as to avoid biotoxicity. Here we report the synthesis of the polyethyleneimine-fluorescein isothiocyanate-folic acid (PEI-FITC-FA) polymer, which could condense the tumor suppressor pp53 to form nanocomplexes. These targeted nanocomplexes exhibited favorable physical properties including a small size of <100 nm, exploiting the enhanced permeability and retention effect and tumor-targeting ability by binding to the overexpressed FA receptors on tumor cell surfaces. In addition, once the nanocomplexes are accumulating in the tumor tissue, the target functional ligand, FA, can selectively recognize the over-expressed FA receptor and subsequently remain on the tumor cell surface, which can significantly promote the tumor cell uptake because of the time- and concentration-dependent internalization caused by the enhanced interaction between nanocomplex and tumor cell. Our results indicated that PEI-FITC-FA/pp53 nanocomplexes could be efficiently delivered into tumor cells, and subsequently induce tumor cell apoptosis. Thus, the targeted cationic polymer PEI-FITC-FA could be used as an advanced nanocarrier for gene delivery.
Collapse
Affiliation(s)
- Yuan Zhong
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing, 400030, People's Republic of China
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Near-infrared-emitting persistent luminescent nanoparticles modified with gold nanorods as multifunctional probes for detection of arsenic(III). Mikrochim Acta 2019; 186:197. [DOI: 10.1007/s00604-019-3294-z] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Accepted: 02/02/2019] [Indexed: 01/31/2023]
|
15
|
Villaverde G, Baeza A. Targeting strategies for improving the efficacy of nanomedicine in oncology. BEILSTEIN JOURNAL OF NANOTECHNOLOGY 2019; 10:168-181. [PMID: 30746311 PMCID: PMC6350877 DOI: 10.3762/bjnano.10.16] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/11/2018] [Accepted: 12/19/2018] [Indexed: 05/21/2023]
Abstract
The use of nanoparticles as drug carriers has provided a powerful weapon in the fight against cancer. These nanocarriers are able to transport drugs that exhibit very different nature such as lipophilic or hydrophilic drugs and big macromolecules as proteins or RNA. Moreover, the external surface of these carriers can be decorated with different moieties with high affinity for specific membrane receptors of the tumoral cells to direct their action specifically to the malignant cells. The selectivity improvement yielded by these nanocarriers provided a significative enhancement in the efficacy of the transported drug, while the apparition of side effects in the host was reduced. Additionally, it is possible to incorporate targeting moieties selective for organelles of the cell, which improves even more the effect of the transported agents. In the last years, more sophisticated strategies such as the use of switchable, hierarchical or double targeting strategies have been proposed for overcoming some of the limitations of conventional targeting strategies. In this review, recent advances in the development of targeted nanoparticles will be described with the aim to present the current state of the art of this technology and its huge potential in the oncological field.
Collapse
Affiliation(s)
- Gonzalo Villaverde
- Dpto. Química Inorgánica y Bioinorgánica, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria, Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Madrid, Spain
| | - Alejandro Baeza
- Dpto. Materiales y Producción Aeroespacial, ETSI Aeronáutica y del Espacio, Universidad Politécnica de Madrid, 28040-Madrid, Spain
| |
Collapse
|
16
|
Ravindran Girija A, Balasubramanian S. Theragnostic potentials of core/shell mesoporous silica nanostructures. Nanotheranostics 2019; 3:1-40. [PMID: 30662821 PMCID: PMC6328307 DOI: 10.7150/ntno.27877] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2018] [Accepted: 09/22/2018] [Indexed: 12/14/2022] Open
Abstract
Theragnostics is considered as an emerging treatment strategy that integrates therapeutics and diagnostics thus allowing delivery of therapeutics and simultaneous monitoring of the progression of treatment. Among the different types of inorganic nanomaterials that are being used for nanomedicine, core shell mesoporous silica nanoparticles have emerged as promising multifunctional nanoplatform for theragnostic application. Research in the design of core/shell mesoporous silica nanoparticles is steadily diversifying owing to the various interesting properties of these nanomaterials that are advantageous for advanced biomedical applications. Core/shell mesoporous silica nanoparticles, have garnered substantial attention in recent years because of their exceptional properties including large surface area, low density, ease of functionalization, high loading capacity of drugs, control of the morphology, particle size, tunable hollow interior space and mesoporous shell and possibility of incorporating multifunctional interior core material. In the past decade researcher's demonstrated tremendous development in design of functionalized core/shell mesoporous silica nanoparticles with different inorganic functional nanomaterial incorporated into mesoporous nanosystem for simultaneous therapeutic and diagnostic (theragnostic) applications in cancer. In this review, we recapitulate the progress in commonly used synthetic strategies and theragnostic applications of core/shell mesoporous silica nanoparticles with special emphasis on therapeutic and diagnostic modalities. Finally, we discuss the challenges and some perspectives on the future research and development of theragnostic core/shell mesoporous silica nanoparticles.
Collapse
Affiliation(s)
- Aswathy Ravindran Girija
- Future Industries Institute, University of South Australia Mawson Lakes Campus, Mawson Lakes 5095, SA, Australia
| | - Sivakumar Balasubramanian
- School of Engineering, University of South Australia Mawson Lakes Campus, Mawson Lakes 5095, SA, Australia
| |
Collapse
|
17
|
A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems. Anal Chim Acta 2018; 1036:97-106. [PMID: 30253842 DOI: 10.1016/j.aca.2018.06.038] [Citation(s) in RCA: 63] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Accepted: 06/13/2018] [Indexed: 12/12/2022]
Abstract
The ability to rapidly screen drugs and drug delivery systems with a more accurate tumor model to better predict their in vivo performance is of great importance in drug development, because there have been some limitations in currently used tumor models. To address this problem, we developed an in vitro breast tumor model on a chip, composed of a microvessel wall, the extracellular matrix (ECM) and uniformly sized multicellular tumor spheroids (MCTS), for the evaluation of nanoparticle-based drug delivery systems. A carbon dots (CDs)-based drug delivery system was synthesized as a model to evaluate the real-time monitoring ability of the system transport through the endothelium and the penetrability into MCTS with a high spatio-temporal resolution on the established platform. Moreover, a modified 96-well plate was used to hold the microfluidic devices for in situ cytotoxicity assays of the MCTS by a microplate reader. Our findings revealed that the synthesized drug delivery system could be transported across an endothelial monolayer within 3 h and was nontoxic to the cells throughout the experiment. In addition, we demonstrated the capabilities of this model by assessing the delivery and efficacy of the drug delivery system in BT549 and T47D spheroids, two cell lines representative of triple negative breast cancer (TNBC) and non-TNBC, respectively. This microfluidic platform enables evaluation of dynamic transport behavior and in situ cytotoxicity evaluation in one system. The established platform provides a more accurate and low-cost in vitro model for rapid drug screening in pre-clinical studies.
Collapse
|
18
|
Chen J, Wu Q, Luo L, Wang Y, Zhong Y, Dai HB, Sun D, Luo ML, Wu W, Wang GX. Dual tumor-targeted poly(lactic- co-glycolic acid)-polyethylene glycol-folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery. Int J Nanomedicine 2017; 12:5745-5760. [PMID: 28848351 PMCID: PMC5557624 DOI: 10.2147/ijn.s136488] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Further specific target-ability development of biodegradable nanocarriers is extremely important to promote their security and efficiency in antitumor drug-delivery applications. In this study, a facilely prepared poly(lactic-co-glycolic acid) (PLGA)-polyethylene glycol (PEG)-folic acid (FA) copolymer was able to self-assemble into nanoparticles with favorable hydrodynamic diameters of around 100 nm and negative surface charge in aqueous solution, which was expected to enhance intracellular antitumor drug delivery by advanced dual tumor-target effects, ie, enhanced permeability and retention induced the passive target, and FA mediated the positive target. Fluorescence-activated cell-sorting and confocal laser-scanning microscopy results confirmed that doxorubicin (model drug) loaded into PLGA-PEG-FA nanoparticles was able to be delivered efficiently into tumor cells and accumulated at nuclei. In addition, all hemolysis, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, and zebrafish-development experiments demonstrated that PLGA-PEG-FA nanoparticles were biocompatible and secure for biomedical applications, even at high polymer concentration (0.1 mg/mL), both in vitro and in vivo. Therefore, PLGA-PEG-FA nanoparticles provide a feasible controlled-release platform for secure and efficient antitumor drug delivery.
Collapse
Affiliation(s)
- Jia Chen
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
- Institute of Laboratory Animals, Sichuan Academy of Medical Science, Sichuan Provincial People’s Hospital, Chengdu
| | - Qi Wu
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| | - Li Luo
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| | - Yi Wang
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| | - Yuan Zhong
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| | - Han-Bin Dai
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| | - Da Sun
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
- Institute of Life Sciences, Wenzhou University, Wenzhou
| | - Mao-Ling Luo
- School of Medicine, Wuhan University, Wuhan, China
| | - Wei Wu
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| | - Gui-Xue Wang
- Key Laboratory for Biorheological Science and Technology, Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College, Chongqing University, Chongqing
| |
Collapse
|
19
|
Synthesis of hollow and mesoporous structured NaYF 4 :Yb,Er upconversion luminescent nanoparticles for targeted drug delivery. J RARE EARTH 2017. [DOI: 10.1016/s1002-0721(17)60929-3] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
20
|
Liang X, Fan J, Zhao Y, Cheng M, Wang X, Jin R, Sun T. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles. J Biomater Appl 2017; 31:1247-1256. [PMID: 28350205 DOI: 10.1177/0885328217701289] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
In this paper, multifunctional upconversion luminescent NaYF4:Yb,Er nanoparticles with excellent hollow mesoporous structure were first fabricated. The effects of various reaction conditions on the morphology and size of the as-prepared samples were investigated in detail and Ostwald ripening effect was adapted to explain the formation mechanism of the HMUCNPs. Then, folic acid, a well-known ligand for the selective targeting of drugs into tumor cells, was conjugated to the surface of the hollow mesoporous structured upconversion luminescent nanoparticles (HMUCNPs) via amide reaction for targeted delivery of anticancer drugs so as to enhance the therapeutic efficacy. The properties were extensively studied, which indicated the obtained samples showed a typical hollow mesoporous structure and excellent upconversion luminescence that were useful for cell imaging and drug delivery. Drug storage/release properties were demonstrated to be pH responsive, in which the drug release might be beneficial at the reduced pH in certain cancerous tissues for targeted release and controlled therapy at the pathological sites. Meanwhile, DOX-NaYF4:Yb,Er-FA HMUCNPs exhibited greater cytotoxicity than free doxorubicin hydrochloride because folic acid-conjugated HMUCNPs can be specifically taken up by FR-positive KB cells via a receptor-mediated endocytosis. Therefore, the folic acid-functionalized nanoparticles combining upconversion luminescent property and hollow mesoporous structure have potential for simultaneous targeted anticancer drug delivery and cell imaging.
Collapse
Affiliation(s)
- Xuhua Liang
- 1 College of Biology Pharmacy and Food Engineering, Shangluo University, Shangluo, PR China
| | - Jun Fan
- 2 School of Chemical Engineering, Northwest University, Xi'an, PR China
| | - Yanyan Zhao
- 1 College of Biology Pharmacy and Food Engineering, Shangluo University, Shangluo, PR China.,2 School of Chemical Engineering, Northwest University, Xi'an, PR China
| | - Min Cheng
- 1 College of Biology Pharmacy and Food Engineering, Shangluo University, Shangluo, PR China
| | - Xuejun Wang
- 1 College of Biology Pharmacy and Food Engineering, Shangluo University, Shangluo, PR China
| | - Ruyi Jin
- 3 Shenzhen Neptunus Medical Science and Technology Research Institute, Shenzhen, PR China
| | - Tao Sun
- 4 School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, PR China
| |
Collapse
|
21
|
Luo Y, Huang L, Yang Y, Zhuang X, Hu S, Ju H, Yu BY, Tian J. A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting. Am J Cancer Res 2017; 7:1245-1256. [PMID: 28435462 PMCID: PMC5399590 DOI: 10.7150/thno.18187] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Accepted: 01/16/2017] [Indexed: 01/08/2023] Open
Abstract
To achieve the best therapeutic efficacy and good prognosis, the drugs necessitate tailored profiles of excellent spatiotemporal control and therapeutic monitoring. Here we introduce a programmed theranostic nanoparticle with self-adapting properties for tumor-specific systemic treatment, including stealthy surface to prolong circulation time in blood, surface charge-reversion for tumor targeting, receptor-mediated internalization to increase intracellular accumulation, “proton sponge effect” for controllable drug release and escape from endo/lysosome. Encouragingly, in the process of drug-induced apoptosis, the therapeutic efficacy can be reported by fluorescence imaging in vivo, in situ and in real time. Therefore, this work provides a new paradigm for design of programmed theranositc nanomedicine and offers promising prospects for precise tumor treatment.
Collapse
|
22
|
Luo T, Sun J, Zhu S, He J, Hao L, Xiao L, Zhu Y, Wang Q, Pan X, Wang Z, Chang S. Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts. Cancer Lett 2016; 391:1-11. [PMID: 28043912 DOI: 10.1016/j.canlet.2016.12.032] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Revised: 12/21/2016] [Accepted: 12/22/2016] [Indexed: 12/20/2022]
Abstract
Folate receptor (FR) is overexpressed in many epithelial cancers and tumor-associated macrophages (TAMs), which enable it to function as an appropriate target for cancer treatment. We have successfully synthesized multifunctional folate-targeted and oxygen/paclitaxel loaded microbubbles (TOPLMBs) for ultrasound (US) mediated delivery for combination therapy in an intraperitoneal ovarian cancer xenograft model. The TOPLMBs target both ovarian cancer cells and TAMs and provide a promising drug delivery strategy for the combination treatment of ovarian cancer and tumor microenvironment. Microscopic imaging and flow cytometric analysis showed that TOPLMBs significantly penetrated into ovarian cancer cells and tumor-associated macrophages (TAMs) within tumor ascites fluid and the tumor nodules. Immunohistochemical analyses of dissected tumor tissue confirmed the increased tumor apoptosis, the reduced expression of vascular endothelial growth factor (VEGF) and microvascular density (MVD), and the reduced expression of CD68 after treatment (P < 0.05). Our experiment results suggest that intraperitoneal injection of dual-targeting TOPLMBs followed by US mediation provide a promising drug delivery strategy for combination treatment of ovarian cancer and tumor microenvironment with the therapeutic outcome superior to that of conventional therapeutic options.
Collapse
Affiliation(s)
- Tingting Luo
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; Institute of Ultrasound Imaging, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Jiangchuan Sun
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Shenyin Zhu
- Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - Juan He
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Lan Hao
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Linlin Xiao
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Yi Zhu
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Qianqian Wang
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Xin Pan
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Zhigang Wang
- Institute of Ultrasound Imaging, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
| | - Shufang Chang
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
| |
Collapse
|
23
|
Mashhadi Malekzadeh A, Ramazani A, Tabatabaei Rezaei SJ, Niknejad H. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy. J Colloid Interface Sci 2016; 490:64-73. [PMID: 27870961 DOI: 10.1016/j.jcis.2016.11.014] [Citation(s) in RCA: 86] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Revised: 11/03/2016] [Accepted: 11/05/2016] [Indexed: 12/20/2022]
Abstract
Magnetic drug targeting is a drug delivery strategy that can be used to improve the therapeutic efficiency on tumor cells and reduce the side effects on normal cells and tissues. The aim in this study is designing a novel multifunctional drug delivery system based on superparamagnetic nanoparticles for cancer therapy. Magnetic nanoparticles were synthesized by coprecipitation of iron oxide followed by coating with poly citric acid (PCA) dendritic macromolecules via bulk polymerization strategy. It was further surface-functionalized with poly(ethylene glycol) (PEG) and then to achieve tumor cell targeting property, folic acid was further incorporated to the surface of prepared carriers via a facile coupling reaction between the hydroxyl end group of the PEG and the carboxyl group of folic acid. The so prepared nanocarriers (Fe3O4@PCA-PEG-FA) were characterized by X-ray diffraction, TEM, TGA, FT-IR, DLS and VSM techniques. The room temperature VSM measurements showed that magnetic particles were superparamagnetic. Transmission electron microscopy and dynamic light scattering were also performed which revealed that size of nanocarriers was lying in the range of 10-49nm. Quercetin loading and release profiles of prepared nanocarriers showed that up to 83% of loaded drug was released in 250h. Fluorescent microscopy showed that the cellular uptake by folate receptor-overexpressing HeLa cells of the quercetin-loaded Fe3O4@PCA-PEG-FA nanoparticles was higher than that of non-folate conjugated nanoparticles. Thus, folate conjugation significantly increased nanoparticle cytotoxicity. Also, T2-weighted MRI images of Fe3O4@PCA-PEG-FA nanoparticles showed that the magnetic resonance signal is enhanced significantly with increasing nanoparticle concentration in water and they also served as MRI contrast agents with relaxivities of 3.4mM-1s-1 (r1) and 99.8mM-1s-1 (r2). The results indicate that this multifunctional nanocarrier is a significant breakthrough in developing a drug delivery vehicle that combines drug targeting as well as sensing and therapy at the same time.
Collapse
Affiliation(s)
| | - Ali Ramazani
- Department of Chemistry, Faculty of Science, University of Zanjan, P.O. Box 45195-313, Zanjan, Iran.
| | | | - Hassan Niknejad
- Department of Tissue Engineering, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Nanomedicine and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
24
|
Drees C, Raj AN, Kurre R, Busch KB, Haase M, Piehler J. Engineered Upconversion Nanoparticles for Resolving Protein Interactions inside Living Cells. Angew Chem Int Ed Engl 2016; 55:11668-72. [PMID: 27510808 DOI: 10.1002/anie.201603028] [Citation(s) in RCA: 95] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2016] [Revised: 06/29/2016] [Indexed: 01/05/2023]
Abstract
Upconversion nanoparticles (UCNPs) convert near-infrared into visible light at much lower excitation densities than those used in classic two-photon absorption microscopy. Here, we engineered <50 nm UCNPs for application as efficient lanthanide resonance energy transfer (LRET) donors inside living cells. By optimizing the dopant concentrations and the core-shell structure for higher excitation densities, we observed enhanced UCNP emission as well as strongly increased sensitized acceptor fluorescence. For the application of these UCNPs in complex biological environments, we developed a biocompatible surface coating functionalized with a nanobody recognizing green fluorescent protein (GFP). Thus, rapid and specific targeting to GFP-tagged fusion proteins in the mitochondrial outer membrane and detection of protein interactions by LRET in living cells was achieved.
Collapse
Affiliation(s)
- Christoph Drees
- Abteilung für Biophysik, Fachbereich Biologie/Chemie, Universität Osnabrück, Barbarastrasse 11, 49076, Osnabrück, Germany
| | - Athira Naduviledathu Raj
- Institut für Chemie Neuer Materialien, Fachbereich Biologie/Chemie, Universität Osnabrück, Barbarastrasse 7, 49069, Osnabrück, Germany
| | - Rainer Kurre
- Center for Advanced Light Microscopy, Fachbereich Biologie/Chemie, Universität Osnabrück, Barbarastrasse 11, 49076, Osnabrück, Germany
| | - Karin B Busch
- Fachbereich Biologie, Universität Münster, Schlossplatz 5, 48149, Münster, Germany
| | - Markus Haase
- Institut für Chemie Neuer Materialien, Fachbereich Biologie/Chemie, Universität Osnabrück, Barbarastrasse 7, 49069, Osnabrück, Germany.
| | - Jacob Piehler
- Abteilung für Biophysik, Fachbereich Biologie/Chemie, Universität Osnabrück, Barbarastrasse 11, 49076, Osnabrück, Germany.
| |
Collapse
|
25
|
Drees C, Raj AN, Kurre R, Busch KB, Haase M, Piehler J. Maßgeschneiderte Aufwärtskonvertierungsnanopartikel zur Detektion von Proteinwechselwirkungen in lebenden Zellen. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201603028] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Christoph Drees
- Abteilung für Biophysik, Fachbereich Biologie/Chemie; Universität Osnabrück; Barbarastraße 11 49076 Osnabrück Deutschland
| | - Athira Naduviledathu Raj
- Institut für Chemie Neuer Materialien, Fachbereich Biologie/Chemie; Universität Osnabrück; Barbarastraße 7 49069 Osnabrück Deutschland
| | - Rainer Kurre
- Center for Advanced Light Microscopy, Fachbereich Biologie/Chemie; Universität Osnabrück; Barbarastraße 11 49076 Osnabrück Deutschland
| | - Karin B. Busch
- Fachbereich Biologie; Universität Münster; Schlossplatz 5 48149 Münster Deutschland
| | - Markus Haase
- Institut für Chemie Neuer Materialien, Fachbereich Biologie/Chemie; Universität Osnabrück; Barbarastraße 7 49069 Osnabrück Deutschland
| | - Jacob Piehler
- Abteilung für Biophysik, Fachbereich Biologie/Chemie; Universität Osnabrück; Barbarastraße 11 49076 Osnabrück Deutschland
| |
Collapse
|
26
|
Bagheri A, Arandiyan H, Boyer C, Lim M. Lanthanide-Doped Upconversion Nanoparticles: Emerging Intelligent Light-Activated Drug Delivery Systems. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2016; 3:1500437. [PMID: 27818904 PMCID: PMC5069703 DOI: 10.1002/advs.201500437] [Citation(s) in RCA: 93] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2015] [Revised: 01/20/2016] [Indexed: 05/20/2023]
Abstract
The development of drug delivery systems (DDSs) using near infrared (NIR) light and upconversion nanoparticles (UCNPs) has generated intensive interest over the past five years. These NIR-initiated DDSs not only offer a high degree of spatial and temporal determination of therapeutic release but also provide precise control over the released dosage. Furthermore, these nanoplatforms confer several advantages over conventional light-based DDSs-NIR offers better tissue penetration depth and a reduced risk of cellular photo-damage caused by exposure to light at high-energy wavelengths (e.g., ultraviolet light, <400 nm). The development of DDSs that can be activated by low intensity NIR illumination is highly desirable to avoid exposing living tissues to excessive heat that can limit the in vivo application of these DDSs. This encompasses research in three directions: (i) enhancing the quantum yield of the UCNPs; (ii) incorporation of photo-responsive materials with red-shifted absorptions into the UCNPs; and (iii) tuning the UCNPs excitation wavelength. This review focuses on recent advances in the development of NIR-initiated DDS, with emphasis on the use of photo-responsive compounds and polymeric materials conjugated onto UCNPs. The challenges that limit UCNPs clinical applications, alongside with the aforementioned techniques that have emerged to overcome these limitations, are highlighted.
Collapse
Affiliation(s)
- Ali Bagheri
- School of Chemical Engineering The University of New South Wales Sydney NSW 2052 Australia
| | - Hamidreza Arandiyan
- School of Chemical Engineering The University of New South Wales Sydney NSW 2052 Australia
| | - Cyrille Boyer
- Center for Advanced Macromolecular Design (CAMD) and Australian Center for Nano Medicine (ACN) School of Chemical Engineering UNSW Australia Sydney NSW 2052 Australia
| | - May Lim
- School of Chemical Engineering The University of New South Wales Sydney NSW 2052 Australia
| |
Collapse
|
27
|
Pegylated folate and peptide-decorated graphene oxide nanovehicle for in vivo targeted delivery of anticancer drugs and therapeutic self-monitoring. Biosens Bioelectron 2016; 80:519-524. [PMID: 26890827 DOI: 10.1016/j.bios.2016.02.018] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2015] [Revised: 01/19/2016] [Accepted: 02/08/2016] [Indexed: 01/15/2023]
Abstract
This work reports a graphene oxide-based nanovehicle with conjugation of pegylated folate for targeted delivery of anticancer drugs and fluorescein-labeled peptide for therapeutic self-monitoring in vitro and in vivo. The nanovehicle could absorb hydrophobic and aromatic drug molecules with high loading capacity and efficiency of more than 1.7 mg mg(-1) and 90%, respectively. MTT and flow cytometric assays demonstrated that the drug-loaded nanovehicle could specifically transport and release the drugs into the folate receptor high-expressed cancer cells, which ensured a high therapeutic efficiency to cancer cells and prevented the injury to normal cells. Moreover, confocal fluorescence imaging confirmed that the drug-induced cancer cell death could be visualized with the light-up fluorescence of fluorescein activated by caspase-3. The targeted delivery of drug and self-evaluation of therapeutic efficacy were further successfully realized by living imaging in tumor-bearing mice, which broaden the applications of this theranostic system in vivo and may offer new opportunities for precise cancer treatment.
Collapse
|
28
|
Peng Q, Mu H. The potential of protein-nanomaterial interaction for advanced drug delivery. J Control Release 2016; 225:121-32. [PMID: 26812004 DOI: 10.1016/j.jconrel.2016.01.041] [Citation(s) in RCA: 79] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2015] [Revised: 01/22/2016] [Accepted: 01/22/2016] [Indexed: 02/05/2023]
Abstract
Nanomaterials, like nanoparticles, micelles, nano-sheets, nanotubes and quantum dots, have great potentials in biomedical fields. However, their delivery is highly limited by the formation of protein corona upon interaction with endogenous proteins. This new identity, instead of nanomaterial itself, would be the real substance the organs and cells firstly encounter. Consequently, the behavior of nanomaterials in vivo is uncontrollable and some undesired effects may occur, like rapid clearance from blood stream; risk of capillary blockage; loss of targeting capacity; and potential toxicity. Therefore, protein-nanomaterial interaction is a great challenge for nanomaterial systems and should be inhibited. However, this interaction can also be used to functionalize nanomaterials by forming a selected protein corona. Unlike other decoration using exogenous molecules, nanomaterials functionalized by selected protein corona using endogenous proteins would have greater promise for clinical use. In this review, we aim to provide a comprehensive understanding of protein-nanomaterial interaction. Importantly, a discussion about how to use such interaction is launched and some possible applications of such interaction for advanced drug delivery are presented.
Collapse
Affiliation(s)
- Qiang Peng
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2100, Denmark.
| | - Huiling Mu
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2100, Denmark
| |
Collapse
|
29
|
An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release. Biomaterials 2015; 63:115-27. [DOI: 10.1016/j.biomaterials.2015.05.016] [Citation(s) in RCA: 180] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2015] [Revised: 05/01/2015] [Accepted: 05/14/2015] [Indexed: 02/02/2023]
|
30
|
Li T, Shen X, Chen Y, Zhang C, Yan J, Yang H, Wu C, Zeng H, Liu Y. Polyetherimide-grafted Fe₃O₄@SiO2₂ nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging. Int J Nanomedicine 2015; 10:4279-91. [PMID: 26170664 PMCID: PMC4495783 DOI: 10.2147/ijn.s85095] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
Engineering a safe and high-efficiency delivery system for efficient RNA interference is critical for successful gene therapy. In this study, we designed a novel nanocarrier system of polyethyleneimine (PEI)-modified Fe3O4@SiO2, which allows high efficient loading of VEGF small hairpin (sh)RNA to form Fe3O4@SiO2/PEI/VEGF shRNA nanocomposites for VEGF gene silencing as well as magnetic resonance (MR) imaging. The size, morphology, particle stability, magnetic properties, and gene-binding capacity and protection were determined. Low cytotoxicity and hemolyticity against human red blood cells showed the excellent biocompatibility of the multifunctional nanocomposites, and also no significant coagulation was observed. The nanocomposites maintain their superparamagnetic property at room temperature and no appreciable change in magnetism, even after PEI modification. The qualitative and quantitative analysis of cellular internalization into MCF-7 human breast cancer cells by Prussian blue staining and inductively coupled plasma atomic emission spectroscopy analysis, respectively, demonstrated that the Fe3O4@SiO2/PEI/VEGF shRNA nanocomposites could be easily internalized by MCF-7 cells, and they exhibited significant inhibition of VEGF gene expression. Furthermore, the MR cellular images showed that the superparamagnetic iron oxide core of our Fe3O4@SiO2/PEI/VEGF shRNA nanocomposites could also act as a T2-weighted contrast agent for cancer MR imaging. Our data highlight multifunctional Fe3O4@SiO2/PEI/VEGF shRNA nanocomposites as a potential platform for simultaneous gene delivery and MR cell imaging, which are promising as theranostic agents for cancer treatment and diagnosis in the future.
Collapse
Affiliation(s)
- Tingting Li
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Xue Shen
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Yin Chen
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Chengchen Zhang
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Jie Yan
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Hong Yang
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Chunhui Wu
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China ; Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Hongjun Zeng
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China ; Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| | - Yiyao Liu
- Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China ; Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China
| |
Collapse
|
31
|
Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model. Biomaterials 2015; 53:699-708. [DOI: 10.1016/j.biomaterials.2015.02.122] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2014] [Revised: 02/22/2015] [Accepted: 02/27/2015] [Indexed: 12/16/2022]
|
32
|
Li L, Gao F, Jiang W, Wu X, Cai Y, Tang J, Gao X, Gao F. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Drug Deliv 2015; 23:1726-33. [PMID: 25715808 DOI: 10.3109/10717544.2015.1006404] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) have been the subject of extensive research due to their potential biomedical applications. In the present investigation, superparamagnetic FA-PEI-Fe3O4 were successfully prepared and evaluated as a targeted MRI contrast agent. FTIR characteristics, TGA, VSM, and MR imaging confirmed the composition and magnetic properties of the synthesized nanoparticles. TEM showed that FA-PEI-Fe3O4 were spherical in shape and well dispersed. The nanoparticles were superparamagnetic at room temperature with a saturation magnetization value of 67.1 emu/g. The nanoparticles showed higher uptake efficiency due to receptor-mediated endocytosis. Moreover, specificity of FA-PEI-Fe3O4 to target tumor cells was demonstrated by the increased nanoparticle uptake and significant contrast enhancement of KB cells over MCF7 cells. The competitive inhibition of FA-PEI-Fe3O4 by free FA further confirmed the specific interaction of this conjugate with FA receptors. In vivo MR imaging studies showed a decreased signal intensity and enhanced tumor contrast post-injection of FA-PEI-Fe3O4. These results indicate that FA-PEI-Fe3O4 can be used as a promising tumor-targeting agent as well as a T2 negative-contrast agent in MR imaging applications.
Collapse
Affiliation(s)
- Lei Li
- a CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety , Institute of High Energy Physics, Chinese Academy of Sciences , Beijing , China .,b Suzhou Science and Technology Town Hostipal , Jiangsu Province , Suzhou , China
| | - Fumei Gao
- c Lvliang People's Hospital , Shanxi Province , Lvliang , China
| | - Weiwei Jiang
- d Patent Examination Cooperation Jiangsu Center of the Patent Office, SIPO , Jiangsu Province , Suzhou , China , and
| | - Xueliang Wu
- b Suzhou Science and Technology Town Hostipal , Jiangsu Province , Suzhou , China
| | - Yuanyuan Cai
- e Key Laboratory of Particle & Radiation Imaging, Department of Engineering Physics , Ministry of Education, Institute of Medical Physics and Engineering, Tsinghua University , Beijing , China
| | - Jintian Tang
- e Key Laboratory of Particle & Radiation Imaging, Department of Engineering Physics , Ministry of Education, Institute of Medical Physics and Engineering, Tsinghua University , Beijing , China
| | - Xueyun Gao
- a CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety , Institute of High Energy Physics, Chinese Academy of Sciences , Beijing , China
| | - Fuping Gao
- a CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety , Institute of High Energy Physics, Chinese Academy of Sciences , Beijing , China
| |
Collapse
|
33
|
Lv R, Yang G, He F, Dai Y, Gai S, Yang P. Mesoporous NaYF4:Yb,Er@Au–Pt(iv)-FA nanospheres for dual-modal imaging and synergistic photothermal/chemo-anti-cancer therapy. RSC Adv 2015. [DOI: 10.1039/c5ra05437k] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Mesoporous NaYF4:Yb,Er@Au–Pt(iv)-FA up-conversion nanoparticles have been designed for dual-modal imaging-guided anti-cancer therapy, and show excellent inhibition toward cancer cells due to the synergistic photothermal/chemo-therapy.
Collapse
Affiliation(s)
- Ruichan Lv
- Key Laboratory of Superlight Materials and Surface Technology
- Ministry of Education
- College of Material Science and Chemical Engineering
- Harbin Engineering University
- Harbin 150001
| | - Guixin Yang
- Key Laboratory of Superlight Materials and Surface Technology
- Ministry of Education
- College of Material Science and Chemical Engineering
- Harbin Engineering University
- Harbin 150001
| | - Fei He
- Key Laboratory of Superlight Materials and Surface Technology
- Ministry of Education
- College of Material Science and Chemical Engineering
- Harbin Engineering University
- Harbin 150001
| | - Yunlu Dai
- Key Laboratory of Superlight Materials and Surface Technology
- Ministry of Education
- College of Material Science and Chemical Engineering
- Harbin Engineering University
- Harbin 150001
| | - Shili Gai
- Key Laboratory of Superlight Materials and Surface Technology
- Ministry of Education
- College of Material Science and Chemical Engineering
- Harbin Engineering University
- Harbin 150001
| | - Piaoping Yang
- Key Laboratory of Superlight Materials and Surface Technology
- Ministry of Education
- College of Material Science and Chemical Engineering
- Harbin Engineering University
- Harbin 150001
| |
Collapse
|
34
|
White EA, Kenny HA, Lengyel E. Three-dimensional modeling of ovarian cancer. Adv Drug Deliv Rev 2014; 79-80:184-92. [PMID: 25034878 PMCID: PMC4426864 DOI: 10.1016/j.addr.2014.07.003] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Revised: 06/24/2014] [Accepted: 07/01/2014] [Indexed: 12/19/2022]
Abstract
New models for epithelial ovarian cancer initiation and metastasis are required to obtain a mechanistic understanding of the disease and to develop new therapeutics. Modeling ovarian cancer however is challenging as a result of the genetic heterogeneity of the malignancy, the diverse pathology, the limited availability of human tissue for research, the atypical mechanisms of metastasis, and because the origin is unclear. Insights into the origin of high-grade serous ovarian carcinomas and mechanisms of metastasis have resulted in the generation of novel three-dimensional (3D) culture models that better approximate the behavior of the tumor cells in vivo than prior two-dimensional models. The 3D models aim to recapitulate the tumor microenvironment, which has a critical role in the pathogenesis of ovarian cancer. Ultimately, findings using models that accurately reflect human ovarian cancer biology are likely to translate into improved clinical outcomes. In this review we discuss the design of new 3D culture models of ovarian cancer primarily using human cells, key studies in which these models have been applied, current limitations, and future applications.
Collapse
Affiliation(s)
- Erin A White
- Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Center for Integrative Science, University of Chicago, Chicago, IL 60637, USA
| | - Hilary A Kenny
- Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Center for Integrative Science, University of Chicago, Chicago, IL 60637, USA
| | - Ernst Lengyel
- Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Center for Integrative Science, University of Chicago, Chicago, IL 60637, USA.
| |
Collapse
|
35
|
Yang R, An Y, Miao F, Li M, Liu P, Tang Q. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo. Int J Nanomedicine 2014; 9:4231-43. [PMID: 25228802 PMCID: PMC4160329 DOI: 10.2147/ijn.s67210] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND This study aimed to generate targeted folic acid-conjugated, doxorubicin-loaded, magnetic iron oxide bovine serum albumin nanospheres (FA-DOX-BSA MNPs) that lower the side effects and improve the therapeutic effect of antitumor drugs when combined with hyperthermia and targeting therapy. A new nanodrug using magnetic nanospheres for heating and addition of the folate receptor with cancer cell specificity was prepared. The characteristics of these nanospheres and their antitumor effects in nasopharyngeal carcinoma were explored. METHODS FA-DOX-BSA MNPs comprising encapsulated magnetic iron oxide nanoparticles were prepared using a desolvation cross-linking method. Activated folic acid (N-hydroxysuccinimide ester of folic acid) was conjugated to the surface of albumin nanospheres via amino groups. RESULTS Folic acid was successfully expressed on the surface of the nanospheres. Electron microscopy revealed that the FA-DOX-BSA MNPs were nearly spherical and uniform in size, with an average diameter of 180 nm. The nanomaterial could deliver doxorubicin at clinically relevant doses with an entrapment efficiency of 80%. An increasing temperature test revealed that incorporation of magnetic iron oxide into nanospheres could achieve a satisfactory heat treatment temperature at a significantly lower dose when placed in a high-frequency alternating magnetic field. FA-DOX-BSA MNPs showed greater inhibition of tumors than in the absence of folic acid in vitro and in vivo. Compared with chemotherapy alone, hyperthermia combined with chemotherapy was more effective against tumor cells. CONCLUSION Folic acid-conjugated bovine serum albumin nanospheres composed of mixed doxorubicin and magnetic iron oxide cores can enable controlled and targeted delivery of anticancer drugs and may offer a promising alternative to targeted doxorubicin therapy for nasopharyngeal carcinoma.
Collapse
Affiliation(s)
- Rui Yang
- School of Medicine, Southeast University, Nanjing, Jiangsu Province, People's Republic of China
| | - YanLi An
- Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Nanjing, Jiangsu Province, People's Republic of China
| | - FengQin Miao
- School of Medicine, Southeast University, Nanjing, Jiangsu Province, People's Republic of China
| | - MengFei Li
- School of Medicine, Southeast University, Nanjing, Jiangsu Province, People's Republic of China
| | - PeiDang Liu
- School of Medicine, Southeast University, Nanjing, Jiangsu Province, People's Republic of China
| | - QiuSha Tang
- School of Medicine, Southeast University, Nanjing, Jiangsu Province, People's Republic of China
| |
Collapse
|
36
|
Magnetic Fe3O4 nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2014; 42:325-32. [DOI: 10.1016/j.msec.2014.05.041] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/23/2014] [Revised: 04/13/2014] [Accepted: 05/18/2014] [Indexed: 11/21/2022]
|
37
|
Chen G, Qiu H, Prasad PN, Chen X. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem Rev 2014; 114:5161-214. [PMID: 24605868 PMCID: PMC4039352 DOI: 10.1021/cr400425h] [Citation(s) in RCA: 1421] [Impact Index Per Article: 142.1] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2013] [Indexed: 12/15/2022]
Affiliation(s)
- Guanying Chen
- School
of Chemical Engineering and Technology, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China
- Department
of Chemistry and the Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, State University of New York, Buffalo, New York 14260, United States
| | - Hailong Qiu
- School
of Chemical Engineering and Technology, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China
- Department
of Chemistry and the Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, State University of New York, Buffalo, New York 14260, United States
| | - Paras N. Prasad
- Department
of Chemistry and the Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, State University of New York, Buffalo, New York 14260, United States
- Department
of Chemistry, Korea University, Seoul 136-701, Korea
| | - Xiaoyuan Chen
- Laboratory
of Molecular Imaging and Nanomedicine, National
Institute of Biomedical Imaging and Bioengineering, National Institutes
of Health, Bethesda, Maryland 20892-2281, United States
| |
Collapse
|
38
|
Yin Q, Jin X, Yang G, Jiang C, Song Z, Sun G. Biocompatible folate-modified Gd3+/Yb3+-doped ZnO nanoparticles for dualmodal MRI/CT imaging. RSC Adv 2014. [DOI: 10.1039/c4ra08100e] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Folate-modified ZnO:Gd,Yb nanoprobes with good stability and biocompatibility can efficiently induce positive contrast enhancement in T1-weighted MRI and CT imaging.
Collapse
Affiliation(s)
- Qi Yin
- Chemistry and Life Science School
- Changchun University of Technology
- Changchun, P. R. China
| | - Xiaoying Jin
- Chemistry and Life Science School
- Changchun University of Technology
- Changchun, P. R. China
- Advanced Institute of Materials Science
- Changchun University of Technology
| | - Guocheng Yang
- Chemistry and Life Science School
- Changchun University of Technology
- Changchun, P. R. China
- Advanced Institute of Materials Science
- Changchun University of Technology
| | - Chunhuan Jiang
- State Key Laboratory of Electroanalytical Chemistry
- Changchun Institute of Applied Chemistry
- Chinese Academy of Sciences
- Changchun, P. R. China
| | - Zhongkai Song
- Chemistry and Life Science School
- Changchun University of Technology
- Changchun, P. R. China
| | - Guoying Sun
- Chemistry and Life Science School
- Changchun University of Technology
- Changchun, P. R. China
- Advanced Institute of Materials Science
- Changchun University of Technology
| |
Collapse
|
39
|
Yang Y. Upconversion nanophosphors for use in bioimaging, therapy, drug delivery and bioassays. Mikrochim Acta 2013. [DOI: 10.1007/s00604-013-1139-8] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|